Clinical Trial Update: Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of co-administered live attenuated dengue and chikungunya vaccines versus separate administration in adults; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya Fever
• Dengue Fever

Drugs mentioned

• Chikungunya vaccine (live attenuated) (live attenuated chikungunya vaccine)
• Dengue vaccine (live attenuated) (live attenuated dengue vaccine)

Snippet

Sponsor: Butantan Institute | Conditions: Dengue, Chikungunya | Phase 3 | Status: NOT_YET_RECRUITING